These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30344835)

  • 1. Microfluidic platforms for rapid screening of cancer affinity reagents by using tissue samples.
    Hung LY; Fu CY; Wang CH; Chuang YJ; Tsai YC; Lo YL; Hsu PH; Chang HY; Shiesh SC; Hsu KF; Lee GB
    Biomicrofluidics; 2018 Sep; 12(5):054108. PubMed ID: 30344835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An on-chip Cell-SELEX process for automatic selection of high-affinity aptamers specific to different histologically classified ovarian cancer cells.
    Hung LY; Wang CH; Hsu KF; Chou CY; Lee GB
    Lab Chip; 2014 Oct; 14(20):4017-28. PubMed ID: 25144781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated microfluidic platform to perform uninterrupted SELEX cycles to screen affinity reagents specific to cardiovascular biomarkers.
    Sinha A; Gopinathan P; Chung YD; Lin HY; Li KH; Ma HP; Huang PC; Shiesh SC; Lee GB
    Biosens Bioelectron; 2018 Dec; 122():104-112. PubMed ID: 30245322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated microfluidic system for selection of aptamer probes against ovarian cancer tissues.
    Liu WT; Lee WB; Tsai YC; Chuang YJ; Hsu KF; Lee GB
    Biomicrofluidics; 2019 Jan; 13(1):014114. PubMed ID: 30867884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A virus-specific aptamers screened by using an integrated microfluidic system.
    Lai HC; Wang CH; Liou TM; Lee GB
    Lab Chip; 2014 Jun; 14(12):2002-13. PubMed ID: 24820138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
    Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
    Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated microfluidic system for screening of phage-displayed peptides specific to colon cancer cells and colon cancer stem cells.
    Che YJ; Wu HW; Hung LY; Liu CA; Chang HY; Wang K; Lee GB
    Biomicrofluidics; 2015 Sep; 9(5):054121. PubMed ID: 26543513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INTEGRATED MICROFLUIDIC SELEX USING FREE SOLUTION ELECTROKINETICS.
    Olsen TR; Tapia-Alveal C; Yang KA; Zhang X; Pereira LJ; Farmakidis N; Pei R; Stojanovic MN; Lin Q
    J Electrochem Soc; 2017; 164(5):B3122-B3129. PubMed ID: 29170564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in aptamer screening technologies.
    Yan J; Xiong H; Cai S; Wen N; He Q; Liu Y; Peng D; Liu Z
    Talanta; 2019 Aug; 200():124-144. PubMed ID: 31036165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.
    Gopinathan P; Hung LY; Wang CH; Chiang NJ; Wang YC; Shan YS; Lee GB
    Biomicrofluidics; 2017 Jul; 11(4):044101. PubMed ID: 28713479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated microfluidic system for rapid screening of alpha-fetoprotein-specific aptamers.
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2012 May; 35(1):50-55. PubMed ID: 22410487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology.
    Chen C; Zhou S; Cai Y; Tang F
    NPJ Precis Oncol; 2017; 1(1):37. PubMed ID: 29872716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidics in the selection of affinity reagents for the detection of cancer: paving a way towards future diagnostics.
    Hung LY; Wang CH; Fu CY; Gopinathan P; Lee GB
    Lab Chip; 2016 Aug; 16(15):2759-74. PubMed ID: 27381813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
    Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
    Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-Time PCR-Coupled CE-SELEX for DNA Aptamer Selection.
    Ruff P; Pai RB; Storici F
    ISRN Mol Biol; 2012; 2012():939083. PubMed ID: 27335672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advance in phage display technology for bioanalysis.
    Tan Y; Tian T; Liu W; Zhu Z; J Yang C
    Biotechnol J; 2016 Jun; 11(6):732-45. PubMed ID: 27061133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential.
    Tripathi P; Sachan M; Nara S
    Front Chem; 2020; 8():400. PubMed ID: 32500059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of multi-functional capillary electrophoresis for high-efficiency selection of aptamers.
    Zhu C; Yang G; Ghulam M; Li L; Qu F
    Biotechnol Adv; 2019 Dec; 37(8):107432. PubMed ID: 31437572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.